Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-10

FDA Approved: LEVETIRACETAM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for Levetiracetam in Sodium Chloride from Eugia US LLC, adding a salt-form formulation of levetiracetam. This approval e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam in Sodium Chloride (LEVETIRACETAM IN SODIUM CHLORIDE)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM IN SODIUM CHLORIDE)